Soy and Human Health

Soy and Urological Cancer

In a meta-analysis of peer reviewed studies and reports from 1966-1998 by researchers at the West Virginia University School of Medicine revealed that a number of epidemiological studies support the use of dietary agents to protect against various urological forms of cancer, including the bladder, prostate and kidney. (1) A study also shows that isoflavones, such as genistein and daidzein, work synergistically to inhibit cancer growth and induce apotosis. (2)

In a study conducted by Ohio State University researchers, it was found that the effects of diets containing soy protein isolate (whole soy protein with low isoflavone content) and soy phytochemical concentrate (isoflavone-rich soy extract with 85 times the amount of found in soy protein), shows a dose-dependent benefit with regards to higher isoflavones consumption. (3).

For more information on urological cancer, please refer clinical abstracts .

References

  1. J Urol 1999: 161[6]: 1748 -60. In: Angela, P,.LE Magazine November 2000
  2. Clin Cancer Res 2000; 6[1]: 230-6. In Angela, P,.LE Magazine November 2000
  3. J Nutr 1999; 129: 1629-35. In Angela, P,.LE Magazine November 2000